✦ LIBER ✦

2288 – A 12-week, randomized, placebo-controlled study evaluating the efficacy and safety of aripiprazole in combination with lithium/valproate inpartially-responsive bipolar mania

✍ Scribed by Loze, J.-Y.; Landsberg, W.; Rollin, L.; Eudicone, J.M.; Carson, W.H.; McQuade, R.D.

Book ID: 123043767
Publisher: Elsevier Science
Year: 2013
Tongue: French
Weight: 45 KB
Volume: 28
Category: Article
ISSN: 0924-9338
DOI: 10.1016/S0924-9338(13)77147-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind, randomized, placebo-contro

Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania

✍ Zohreh Amrollahi; Farzin Rezaei; Bahman Salehi; Amir-Hossein Modabbernia; Azad M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 311 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled study evaluating the efficacy and safety of naftifine hydrochloride 2% cream and placebo applied daily for 2 weeks in patients with tinea cruris

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Evaluation of the efficacy and safety of

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: Results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

✍ Oliver Distler; Wolfgang Eich; Eva Dokoupilova; Zdenek Dvorak; Martin Fleck; Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

A 24-week, randomized, double-blind, pla

A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease

✍ Nakamura, Yu; Imai, Yukimichi; Shigeta, Masahiro; Graf, Ana; Shirahase, Toru; Ki 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis

✍ Michael Yellin; Igor Paliienko; Andra Balanescu; Semen Ter-Vartanian; Vira Tselu 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

A double-blind, randomized, placebo-cont

A double-blind, randomized, placebo-controlled study to evaluate the efficacy, safety and pharmacodynamics of AT1001 in patients with Fabry disease and AT1001-responsive GLA mutations

✍ Mathews Adera; Chemise Overton; Pol Boudes 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB